Prenetics Global Limited Class A Ordinary Share (PRE) is a publicly traded Healthcare sector company. As of October 25, 2026, PRE trades at $17.36 with a market cap of $338.57M and a P/E ratio of 0.00. PRE moved +5.01% today. Year to date, PRE is +9.95%; over the trailing twelve months it is -0.17%. Its 52-week range spans $3.09 to $27.24. Analyst consensus is strong buy with an average price target of $40.40. Rallies surfaces PRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PRE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $17.36 |
| Market Cap | $338.57M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.70% |
| 52-Week High | $27.24 |
| 52-Week Low | $3.09 |
| Volume | 153.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.39B |
| Net Income | $74.63M |
| Gross Margin | 14.89% |
6 analysts cover PRE: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.40.